Nomifensine (maleate)

CAS No. 32795-47-4

Nomifensine (maleate)( (±)-Nomifensine maleat )

Catalog No. M22410 CAS No. 32795-47-4

Nomifensine maleate is a selective inhibitor of dopamine uptake, used in adult attention deficit disorder.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 48 In Stock
10MG 29 In Stock
25MG 43 In Stock
50MG 60 In Stock
100MG 99 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Nomifensine (maleate)
  • Note
    Research use only, not for human use.
  • Brief Description
    Nomifensine maleate is a selective inhibitor of dopamine uptake, used in adult attention deficit disorder.
  • Description
    Nomifensine maleate is a selective inhibitor of dopamine uptake, used in adult attention deficit disorder.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    (±)-Nomifensine maleat
  • Pathway
    GPCR/G Protein
  • Target
    Dopamine Receptor
  • Recptor
    dopamine uptake
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    32795-47-4
  • Formula Weight
    354.4
  • Molecular Formula
    C20H22N2O4
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:80 mg/mL (225.73 mM); H2O:2.2 mg/mL (6.21 mM; Need ultrasonic)
  • SMILES
    OC(=O)\C=C/C(O)=O.CN1CC(c2ccccc2)c2cccc(N)c2C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Kinney J L . Nomifensine maleate: a new second-generation antidepressant.[J]. Clinical Pharmacy, 1985, 4(6):625-636.
molnova catalog
related products
  • carfenazine

    carfenazine targets the Dopamine receptor and is used for schizophrenia research.

  • Syrosingopine

    Syrosingopine has selective depleting effect on brain amines is potentiated by combined treatment with disulfiram or fusaric acid, a dopamine beta-hydroxylase inhibitor.

  • Levosulpiride

    Levosulpiride is the (S)-enantiomer of sulpiride, which is a D2 receptor a antagonist, an atypical antipsychotic drug of the benzamide class.